1 / 25

MINIMIZING INTRA-OP TRANSFUSION REQUIREMENTS

MINIMIZING INTRA-OP TRANSFUSION REQUIREMENTS. DR. NYAMARI FACILITATOR: DR. BHOYYO KIBET. RATIONALE. To minimize hazards associated with blood transfusion Hazards include infection, immunologic reactions, hypothermia, volume overload, dilutional coagulopathy,

phil
Télécharger la présentation

MINIMIZING INTRA-OP TRANSFUSION REQUIREMENTS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MINIMIZING INTRA-OP TRANSFUSION REQUIREMENTS DR. NYAMARI FACILITATOR: DR. BHOYYO KIBET

  2. RATIONALE • To minimize hazards associated with blood transfusion • Hazards include infection, immunologic reactions, hypothermia, volume overload, dilutional coagulopathy, • Conservation and optimal use of blood resources due to perennial blood shortage • To improve outcomes in patients objecting blood transfusion for religious/personal reasons

  3. TRANSFUSION THRESHOLD • ABLEBV • EBV • Premature neonates 95mL/kg • Full term neonate 85mL/kg • Infants 80mL/kg • Adult men 75mL/kg • Adult women 65mL/kg

  4. STRATEGIES • Patient optimization • Minimization of blood losses • Alternatives to allogeneic blood

  5. PATIENT OPTIMIZATION • Correction of anemia, thrombocytopenia • Optimize hemostatic function; stopping anti-coagulant therapy early, NSAIDs, correction of coagulopathies • Minimizing diagnostic phlebotomy • Pre-operative Autologous Donation(PAD)

  6. PAD • This involves a patient scheduled for elective surgery donating blood prior to surgery • Hb≥ 11g/dl or HCT ≥33% (AABB standards) • Donation done weekly at 10.5ml/kg • Efficacy is dependent on the patient’s intrinsic increase in erythropoiesis • Endogenous erythropoietin response is sub optimal resulting in only 11% expansion of RBC volume • Recombinant erythropoietin and daily iron supplements aid.

  7. PAD ADVANTAGES • Limits transfusion transmitted diseases • Prevents red cell alloimmunization • Provides compatible blood • Provides patient reassurance

  8. PAD DISADVANTAGES • Doesn’t reduce risk of contamination • May result in wastage of blood not transfused(5%) • Risk of perioperative anemia • More expensive

  9. PAD CONTRAINDICATIONS • Evidence of infection • Scheduled surgery for aortic stenosis • Unstable angina, MI, CVA, Cyanotic heart dx • Uncontrolled hypertension

  10. MINIMIZING BLOOD LOSS • Acute NormovolemicHemodilution(ANH) • Intra-operative cell salvage • Surgical technique • Anesthetic technique • Pharmacologic manipulation

  11. ANH • Removal of whole blood from a patient while restoring the circulating volume with acellular fluid shortly before significant blood loss • End point is a Hct of 27%-33% • Blood collected in standard blood bags, stored at room temperature • Re-infused during surgery after major blood loss ceases( within 8hrs) • Re-infusion is done in reverse order.

  12. ANH • The chief benefit is the reduction of RBC losses. • Concomitant decrease in arterial oxygen capacity • Compensatory increase in Cardiac output and reduction in peripheral resistance.

  13. ANH CRITERIA • Likelihood of transfusion exceeds 10% • Absence of cardiac, hepatic or renal dx • Absence of hypertension • Absence of infection

  14. ANH v/s PAD

  15. INTRA-OP BLOOD SALVAGE • Involves the collection of blood from the surgical field into a cell salvage device. • The cell salvage device: • Filters the collected blood(40nm filters) i.e. bone fragments, tissue debris • Anti-coagulates the blood • Separates RBCs from other cellular and liquid elements • Washes salvaged RBCs extensively with saline • The RBCs are then re-infused suspended in saline

  16. CELL SALVAGE MACHINE

  17. INTRA-OP BLOOD SALVAGE INDICATIONS • Aortic reconstruction • Spinal instrumentation • Joint arthroplasty • Liver transplantation • Resection of A-V malformations • Trauma patients

  18. INTRA-OP BLOOD SALVAGE CONTRAINDICATIONS • Infection • Malignant cells • Urine and bowel contents in operating field • Amniotic fluid • Procoagulant material used in surgical field

  19. INTRA-OP BLOOD SALVAGE COMPLICATIONS • Massive air embolism • Dilutional coagulopathy • Nephrotoxicty by free Hb ( limit suction pressures to 150mmHg)

  20. ANAESTHETIC TECHNIQUE • Maintainance of normothermia • Use of regional anesthesia when possible e.g. TJR surgery • Patient positioning • Avoiding high intra-thoracic pressures • Controlling blood pressure • Permissive hypotension • Controlling and maintaining a normal pCO2

  21. SURGICAL TECHNIQUE • Meticulous surgical hemostasis • Use of diathermy, laser scapel • Use of tourniquet where applicable • Minimally invasive procedures if possible

  22. PHARMACOLOGIC AGENTS • Serine protease inhibitors e.g. Aprotinin that are direct plasmin inhibitors • Lysine analogues e.g. Tranexamic acid that inhibit conversion of plasminogen to plasmin • Desmopressin that stimulates the release of vWF promoting primary haemostasis • Recombinant activated factor VIIa • Fibrin glue

  23. ALTERNATIVES TO BLOOD • Substances used to mimic and fulfill functions of biological blood especially oxygen ‘carrying’ • Hemoglobin based oxygen carriers • Perfluorocarbon based oxygen carriers

  24. CONCLUSION • Adhere to protocols on transfusion of blood and its products • Where protocols are non-existent, develop the protocols • Pre-operative assessment and work-up of patients

  25. REFERENCES • Miller’s anesthesia, 7th edition Autologous Transfusion, Recombinant Factor VIIa, and Bloodless Medicine Lawrence T. Goodnough,Terri G. Monk • Clinical Anesthesia, 6th Edition Hemostasis and Transfusion Medicine Barash, Paul G.; Cullen, Bruce F.; Stoelting, Robert K.; Cahalan, Michael K.; Stock, M. Christine

More Related